- Home
- ZNTL vs REFI Comparison
ZNTL vs REFI Comparison
Compare ZNTL & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | REFI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 255.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | REFI |
|---|---|---|
| Price | $1.34 | $12.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $5.87 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 508.5K | 112.7K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 15.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | $26,865,000.00 | ★ $54,287,847.00 |
| Revenue This Year | N/A | $13.78 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $7.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $11.85 |
| 52 Week High | $3.33 | $16.29 |
Technical Indicators
Market Signals| Indicator | ZNTL | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 53.16 |
| Support Level | $1.34 | $12.66 |
| Resistance Level | $1.45 | $13.49 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 14.71 | 51.48 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.